{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:53:09Z","timestamp":1793638389907,"version":"4.5.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cmi.2025.07.002","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:09:33Z","timestamp":1752602973000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility Testing (EUCAST) breakpoints"],"prefix":"10.1016","volume":"32","author":[{"given":"Maiken Cavling","family":"Arendrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Guinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelco F.J.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem B.","family":"Buil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dannaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Giske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlina","family":"Lyskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Meletiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken Cavling","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Meletiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem B.","family":"Buil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dannaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlina","family":"Lyskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Giske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Amilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena-Ros","family":"\u00c1smundsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barchiesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Vildersh\u00f8j","family":"Bj\u00f8rnholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hella","family":"J\u00e4rv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kurzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ccornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeja","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Vrioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.07.002_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3201\/eid1910.130393","article-title":"New clonal strain of Candida auris, Delhi, India","volume":"19","author":"Chowdhary","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.002_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae042","article-title":"Candida auris-a systematic review to inform the world health organization fungal priority pathogens list","volume":"62","author":"Kim","year":"2024","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2025.07.002_bib3","article-title":"[The first two cases of Candida auris in Denmark]","volume":"184","author":"Theut","year":"2022","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.cmi.2025.07.002_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/myc.13655","article-title":"Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates","volume":"66","author":"Spruijtenburg","year":"2023","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2025.07.002_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1128\/aac.00423-23","article-title":"Novel non-hot spot modification in Fks1 of Candida auris Confers Echinocandin resistance","volume":"67","author":"Kordalewska","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.002_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.002_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00485-17","article-title":"Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values","volume":"61","author":"Arendrup","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106558","article-title":"Head-to-head comparison of CLSI, EUCAST, Etest and VITEK\u00ae2 results for Candida auris susceptibility testing","volume":"59","author":"Ceballos-Garzon","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2025.07.002_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/aac.01419-22","article-title":"Clinical efficacy and safety of a novel antifungal, fosmanogepix, in patients with candidemia caused by Candida auris: Results from a phase 2 trial","volume":"67","author":"Vazquez","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.002_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13752","article-title":"Multicenter Candida auris outbreak caused by azole-susceptible clade IV in Pernambuco, Brazil","volume":"67","author":"Spruijtenburg","year":"2024","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2025.07.002_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/myc.13320","article-title":"Axillary digital thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil","volume":"64","author":"Nobrega de Almeida","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2025.07.002_bib12","unstructured":"Clinical Treatment of C. auris infections. CDC n.d. Accessed February 11, 2025. Available at: https:\/\/www.cdc.gov\/candida-auris\/hcp\/clinical-care\/index.html."},{"key":"10.1016\/j.cmi.2025.07.002_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae065","article-title":"Comparative efficacies of the three echinocandins for Candida auris candidemia: Real world evidence from a tertiary centre in India","volume":"62","author":"Prayag","year":"2024","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2025.07.002_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.02788","article-title":"Review on antifungal resistance mechanisms in the emerging pathogen Candida auris","volume":"10","author":"Chaabane","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2025.07.002_bib15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.00367-15","article-title":"Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CL","volume":"53","author":"Kathuria","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2025.07.002_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cmi.2024.10.010","article-title":"Candida auris MIC testing by EUCAST and clinical and laboratory standards institute broth microdilution, and gradient diffusion strips; to be or not to be amphotericin B resistant?","volume":"31","author":"Arendrup","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.002_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/spectrum.04431-22","article-title":"Overestimation of amphotericin B resistance in Candida auris with sensititre yeastone antifungal susceptibility testing: A need for adjustment for correct interpretation","volume":"11","author":"Siopi","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2025.07.002_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01528-23","article-title":"Evaluation of the Vitek 2 system for antifungal susceptibility testing of Candida auris using a representative international panel of clinical isolates: Overestimation of amphotericin B resistance and underestimation of fluconazole resistance","volume":"62","author":"Siopi","year":"2024","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2025.07.002_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/antibiotics13090840","article-title":"Evaluation of Etest and MICRONAUT-AM assay for antifungal susceptibility testing of Candida auris: Underestimation of fluconazole resistance by MICRONAUT-AM and overestimation of amphotericin B resistance by Etest","volume":"13","author":"Asadzadeh","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.cmi.2025.07.002_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drup.2014.01.001","article-title":"Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp","volume":"16","author":"Arendrup","year":"2013","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2025.07.002_bib21","article-title":"A multicentre study for determination of epidemiological cutoff values for rezafungin and four comparators against Candida auris with EUCAST broth microdilution reference methodology","volume":"2025","author":"Meletiadis","year":"2025","journal-title":"ESCMID Glob"},{"key":"10.1016\/j.cmi.2025.07.002_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: An initiative of the ECMM in cooperation with ISHAM and ASM","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.002_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/jof8050499","article-title":"In Vivo Efficacy of Amphotericin B against Four Candida auris Clades","volume":"8","author":"Forg\u00e1cs","year":"2022","journal-title":"J Fungi"},{"key":"10.1016\/j.cmi.2025.07.002_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00306-21","article-title":"In Vitro and In Vivo Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris","volume":"65","author":"Herrada","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.002_bib25","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/jac\/dky153","article-title":"Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model","volume":"73","author":"Hager","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.07.002_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00791-17","article-title":"Pharmacodynamic optimization for treatment of invasive Candida auris infection","volume":"61","author":"Lepak","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.002_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/jiad583","article-title":"Defining optimal doses of liposomal amphotericin B against Candida auris: Data from an in vitro pharmacokinetic\/pharmacodynamic model","volume":"229","author":"Beredaki","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.002_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13061586","article-title":"Candida auris infection, a rapidly emerging threat in the neonatal intensive care units: A systematic review","volume":"13","author":"Sokou","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.cmi.2025.07.002_bib29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.cmi.2020.06.007","article-title":"How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)","volume":"26","author":"Arendrup","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.002_bib30","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.01763-15","article-title":"Posttreatment antifungal resistance among colonizing Candida isolates in candidemia patients: results from a systematic multicenter study","volume":"60","author":"Jensen","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.002_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12831","article-title":"Mechanisms of echinocandin antifungal drug resistance","volume":"1354","author":"Perlin","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cmi.2025.07.002_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/dkac373","article-title":"Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin","volume":"78","author":"Arendrup","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.07.002_bib33","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/jac\/dkad055","article-title":"Development and preliminary validation of a modified EUCAST yeast broth microdilution MIC method with Tween 20-supplemented medium for rezafungin","volume":"78","author":"Zuill","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.07.002_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01393-19","article-title":"In vitro antifungal combination of flucytosine with amphotericin B, voriconazole, or micafungin against Candida auris shows no antagonism","volume":"63","author":"Bidaud","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25003404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25003404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:27:23Z","timestamp":1772882843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25003404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1198743X25003404"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.07.002","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility Testing (EUCAST) breakpoints","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}